NIDA - Research Monographs - Monograph 138: Imaging Techniques in Medications Development: Preclinical and Clinical Aspects

[Finished Printing? - Click Here to Return to Normal View]

	NIDA Home > Publications > Research Monographs >
	Imaging Techniques in Medications Development: Preclinical and Clinical Aspects

NIDA Research Monograph, Number 138 [Printed in 1994]

If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph138.pdf - Imaging Techniques in Medications Development: Preclinical and Clinical Aspects (1.7 MB)

Table of Contents

PET, SPECT, and Probes in Drug Design and Development-----1
Henry N. Wagner, Jr.

Positron Emission Tomography in Studies of Drug Abuse-----15
Edythe D. London

Imaging Brain Function in Animals To Understand Drugs of Abuse and Potential Pharmacotherapies-----25
M.F. Piercey

Brain-Imaging Studies of the Combined Use of Cocaine and Alcohol and of the Pharmacokinetics of Cocaethylene-----41
Nora D. Volkow and Joanna S. Fowler

Positron Emission Tomography of Cocaine Binding Sites on the Dopamine Transporter-----57
Bertha K. Madras, David R. Elmaleh, Peter C. Meltzer, Anna Y. Liang, Gordon L. Brownell, and Anna-Liisa Brownell

Metabolic Mapping Methods for the Identification of the Neural Substrates of the Effects of Novel Tropane Analogs-----71
Linda J. Porrinno, Lisa Williams-Hemby, and Huw M.L. Davies

Noninvasive Evaluation of the Sympathetic Nervous System of the Heart by Nuclear Imaging Procedures-----85
Markus Schwaiger, James C. Sisson, and Donald Wieland

Development of PET/SPECT Ligands for the Serotonin Transporter-----111
Ursula Scheffel, Robert F. Dannals, Makiko Suehiro, George A. Ricaurte, F. Ivy Carroll, Michael J. Kuhar, and Henry N. Wagner, Jr.

SPECT Imaging of Dopamine and Serotonin Transporters in Nonhuman Primate Brain-----131
Marc Laruelle, Ronald M. Baldwin, and Robert B. Innis

Cerebra Blood Flow Changes With Acute Cocaine Intoxication: Clinical Correlations With SPECT, CT, and MRI-----161
I. Mena, R.J. Giornbetti, B.L. Miller, K. Garrett, J. Villanueva-Meyer, C. Mody, and M.A. Goldberg

An Introduction to Magnetic Resonance Methods for Clinical Research-----175
Gerald G. Blackwell

Advanced Search \| FAQs \| Accessibility \| Site Map \| Help \| NIDA Home \| Privacy Policy \| FOIA (NIH) \| Employment \| Print Version
	The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.